Cronos Group Inc. (CRON)
| Market Cap | 1.03B |
| Revenue (ttm) | 146.59M |
| Net Income (ttm) | -9.45M |
| Shares Out | 379.05M |
| EPS (ttm) | -0.02 |
| PE Ratio | n/a |
| Forward PE | 31.39 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,994,906 |
| Open | 2.690 |
| Previous Close | 2.670 |
| Day's Range | 2.640 - 2.740 |
| 52-Week Range | 1.600 - 3.430 |
| Beta | 1.18 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Feb 26, 2026 |
About CRON
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada. [Read more]
Financial Performance
Financial StatementsNews
Decoding Cronos Group Inc (CRON): A Strategic SWOT Insight
Decoding Cronos Group Inc (CRON): A Strategic SWOT Insight
Cronos Group Inc (CRON) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...
Cronos Group Inc (CRON) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion
Q4 2025 Cronos Group Inc Earnings Call Transcript
Q4 2025 Cronos Group Inc Earnings Call Transcript
Cronos Group Inc. (CRON:CA) Q4 2025 Earnings Call Transcript
Cronos Group Inc. (CRON:CA) Q4 2025 Earnings Call Transcript
Cronos Group Earnings Review: Q4 Summary
The earnings results for Cronos Group (NASDAQ: CRON) for Q4 were made public on Thursday, February 26, 2026 at 07:35 AM. Here's a comprehensive overview of the announcement. Earnings Cronos Group mis...
Insights into Cronos Group Q4 Earnings
Cronos Group (NASDAQ: CRON) released its Q4 earnings on Thursday, February 26, 2026 at 07:35 AM. Here's what's important from the earnings announcement. Earnings Cronos Group missed estimated earning...
Cronos Group GAAP EPS of $0.00 misses by $0.02, revenue of $44.53M beats by $5.78M
Cronos Group Reports 2025 Fourth Quarter and Full-Year Results
Net revenue in Q4 2025 increased by 47% year-over-year to $44.5 million ; Net revenue in FY 2025 increased by 25% year-over-year to $146.6 million
Cronos Group Q4 Earnings Preview
Cronos: Geographic Expansion Backed By A Strong Balance Sheet
Cronos remains a Strong Buy, supported by robust fundamentals, international expansion, and a depressed $1B valuation with $784M in cash. CRON's acquisition of CanAdelaar and expansion into Europe and...
Are Canadian Cannabis Stocks Ready to Rebound? 3 Names to Watch
The Canadian cannabis sector continues to evolve in early 2026. Although volatility remains, investor interest is returning. Regulatory discussions in the United States are once again gaining momentum...
Cronos Launches New All-in-One Vape, Spinach PUFFERZ™
Spinach PUFFERZ™ delivers a flavorful experience combining high-quality cannabis with a sleek tactile design, enhanced with liquid diamonds Spinach PUFFERZ™ delivers a flavorful experience combining h...
3 Top Canadian Marijuana Stocks To Buy Sell Or Hold In 2026
What is it about the cannabis industry that keeps investors searching for top marijuana stocks to buy? Cannabis started as one of the first waves of peace, love, and rebellion towards many cultural in...
Cronos Group Inc. to Hold 2025 Fourth Quarter and Full-Year Earnings Conference Call on February 26, 2026
TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 fourth quarter and full-year earnings conference call on Thursday...
3 Canadian Marijuana Stocks Today's Stock Market That Could Soon Run
The cannabis industry is in another pivotal time where consistent changes are being made. Laws and regulations have been passed across the country that have aided in the further development of industr...
Cronos Group Launches Premium Lord Jones® Brand in Israel, Advancing Borderless Product Strategy
TORONTO, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON; TSX: CRON) (“Cronos” or the “Company”), a leading global cannabinoid company, today announced the launch of its Lord Jones® ...
International Vector Equity Portfolio Buys 10,939 Shares of Cronos Group Inc (CRON)
International Vector Equity Portfolio Buys 10,939 Shares of Cronos Group Inc (CRON)
Park Edge Advisors, LLC Sells 976 Shares of Cronos Group Inc (CRON)
Park Edge Advisors, LLC Sells 976 Shares of Cronos Group Inc (CRON)
International Vector Equity Portfolio Buys 5 Shares of Cronos Group Inc (CRON)
International Vector Equity Portfolio Buys 5 Shares of Cronos Group Inc (CRON)
How to play cannabis stocks in 2026
President Trump's executive order to reschedule marijuana is one of the many things cannabis investors will be watching in 2026. AdvisorShares portfolio manager Dan Ahrens, who manages the firm's Pure...
3 Marijuana Stocks For Investors To Make Money In 2026
Finding the best marijuana stocks in the stock market today may be easier than you think. At one time, it was a simple task to determine which cannabis companies were better to invest in. Even with th...
Marijuana industry taking fight against Wall Street blockades straight to Trump
Bankers have argued that Pot Inc.'s far-bigger prospective business – recreational use that would include the smoking of joints and ingesting high-inducing gummies – wasn't specifically addressed by t...
Best Canadian Cannabis Stocks to Watch Entering 2026
The cannabis industry continues to evolve as investors look toward 2026 with renewed optimism. Canadian cannabis companies remain at the center of global expansion. They benefit from strong medical pr...
Cronos: A Standout Balance Sheet Among Its Peers
Cronos Group operates in a highly competitive industry but has a marked advantage over its peers owing to its vastly superior balance sheet. This superiority is a result of a 2019 investment by Altria...
Trump Is Warming to Cannabis, but Investors Aren't Impressed
Stocks took a surprise tumble after the White House moved to reclassify marijuana as a less dangerous drug.